Skip to main content

Table 1 Comparison of anthropometric and biochemical measurements in T2DM patients and the control group

From: Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus

 

T2DM patients

Control (n = 19) (X + SD)

P value

 

(n = 21) (X + SD)

 

Age

52 ± 11.1

24.3 ± 3.7

<0.005

BMI

32.4 ± 6.0

22.8 ± 1.4

<0.005

Waist cm

103.3 ± 13.8

70.0 ± 7.7

<0.005

Hip cm

109.0 ± 13.3

95.0 ± 7.7

<0.005

% Fat

42.0 ± 8.9

25.6 ± 9.8

<0.005

% Lean mass

58.0 ± 9.0

74.3 ± 9.9

<0.005

Total weight

84.2 ± 17.1

63.1 ± 9.2

<0.005

Glucose 0´

148.2 ± 51.4

83.9 ± 12.5

<0.005

Glucose 30´

ND

ND

ND

Glucose 60´

ND

ND

ND

Glucose 90´

ND

ND

ND

Glucose 120´

ND

ND

ND

Insulin 0´

15.6 ± 7.9

7.3 ± 2.0

<0.005

HOMA IR

5.4 ± 2.7

1.5 ± 0.44

<0.005

Free fatty acids

0.6 ± 0.2

0.5 ± 0.3

>0.05

Beta-hydroxybutyrate

0.2 ± 0.1

0.2 ± 0.04

>0.05

ALP

63 ± 17

62.10 ± 16.9

>0.05

Uric acid

5.8 ± 1.5

5.2 ± 1.0

>0.05

Serum creatinine

0.7 ± 0.17

0.8 ± 0.15

>0.05

Cholesterol

202.5 ± 50.7

200.6 ± 39.6

>0.05

Total bilirubin

0.2 ± 0.10

0.3 ± 0.2

>0.05

Direct bilirubin

.05 ± .02

0.06 ± 0.03

>0.05

Indirect bilirubin

0.15 ± 0.1

0.2 ± 0.1

>0.05

Total protein

8.1 ± 0 .7

8.5 ± 0.9

>0.05

Albumin

4.7 ± 0.5

5.13 ± 0.5

<0.05

Globulin

3.4 ± 0.4

3.4 ± 0.5

>0.05

AST

17 ± 11.5

10.4 ± 2.0

<0.05

ALT

14.5 ± 10.1

8.0 ± 2.6

<0.005

C4

0.24 ± 0.10

0.18 + 0.08

<0.05

C2

10.1 ± 2.2

8.7 ± 1.6

<0.005

Leu

117.7 ± 22.3

96.1 ± 23.7

<0.05

Tyr

51.3 ± 10.4

41.5 ± 11.0

<0.005

Val

165.2 ± 19.0

135.0 ± 31.0

<0.005

Gly

242.0 ± 36.2

226.5 ± 47.0

>0.05

Arg

27.5 ± 9.8

27.4 ± 7.8

>0.05

Cit

18.4 ± 4.7

17.5 ± 4.2

>0.05

Met

21.7 ± 5.1

22.4 ± 5.2

>0.05

Orn

83.7 ± 13.8

76.6 ± 9.6

>0.05

Phe

41.2 ± 6.2

39.3 ± 10.8

>0.05

Ala

288.8 ± 63.0

238.0 ± 44.2

<0.005

  1. NOTE: Parameters in bold were significant.